Coronavirus evacuees monitored at Texas Center for Infectious Disease

Facility’s primary function is to treat tuberculosis patients


The Texas Center for Infectious Disease (TCID) in San Antonio is housing at least five people who tested positive for the coronavirus after being brought to Joint Base San Antonio-Lackland, according to an article on the KSAT website.

More than 18 people have been transferred off base, either to TCID or local hospitals, after showing symptoms of the virus or while awaiting test results.

Local leaders urge Department of Defense to keep coronavirus evacuees away from local healthcare facilities

It's unclear exactly how many of those 18 people are now at TCID.

The primary purpose of TCID is to treat tuberculosis patients.

Read the article.



March 12, 2020


Topic Area: Infection Control


Recent Posts

Making the Energy Efficiency Case to the C-Suite

Hospital executives often wrestle with energy decisions made today that either free up budget for patient care or drain resources that could go elsewhere.


How to Avoid HAIs This Flu Season

There are risks surrounding hospitalizations. Here’s how to avoid them.


Design Phase Set to Begin for Hospital Annex at SUNY Upstate Medical

The design will feature a new, expanded emergency department and burn unit to serve the Central New York Region.


Building Hospital Resilience in an Era of Extreme Weather

Expert Jennifer Mahan discusses the vulnerabilities healthcare facilities face during disasters and the infrastructure strategies that keep operations running.


Ennoble Care Falls Victim to Data Breach

Their investigation into the incident is still ongoing.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.